Concomitant Radio-chemotherapy in the Elderly
The purpose of this study is to evaluate the safety of non small cell lung cancer (NSCLC) treatment with cisplatin and oral vinorelbine administered weekly associated with concomitant radiotherapy in elderly patients.
Non Small Cell Lung Cancer
DRUG: Cisplatin IV|DRUG: Vinorelbine|RADIATION: Radiotherapy
Acute toxicity, during treatment and during the 4 weeks following the end of treatment
Late toxicity, 6 months after the end of the treatment|Overall response rate, 4 weeks after treatment
The purpose of this study is to evaluate the safety of non small cell lung cancer (NSCLC) treatment with cisplatin and oral vinorelbine administered weekly associated with concomitant radiotherapy in elderly patients.